| General Information |
| Business: |
We provide implants, surgical instruments and AI-enabled software for spine fusion surgery. We are currently focused on lumbar spine surgery.
Our aprevo technology platform consists of AI-enabled software solutions, interbody implants custom designed for each patient and single-use surgical instruments.
Note: Net loss and revenue are for the 12 months that ended March 31, 2025.
(Note: Carlsmed, Inc. filed its S-1 to go public on June 26, 2025, without disclosing the terms for its IPO. Estimated initial IPO proceeds are $100 million, a placeholder figure.)
|
| Industry: |
Medical Equipment & Devices |
| Employees: |
100 |
| Founded: |
2018 |
| Contact Information |
| Address |
1800 Aston Ave, Suite 100 Carlsbad, California 92008 |
| Phone Number |
(760) 766-1923 |
| Web Address |
https://www.carlsmed.com./ |
| View Prospectus: |
Carlsmed, Inc. |
| Financial Information |
| Market Cap |
|
| Revenues |
$32.3 mil (last 12 months) |
| Net Income |
$-25.12 mil (last 12 months) |
| IPO Profile |
| Symbol |
CARL |
| Exchange |
NASDAQ |
| Shares (millions): |
0.0 |
| Price range |
$0.00 - $0.00 |
| Est. $ Volume |
$100.0 mil |
| Manager / Joint Managers |
BofA Securities/Goldman Sachs/Piper Sandler |
| CO-Managers |
|
| Expected To Trade: |
|
|
Status:
|
TBA |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
